Serum miR-195 is a diagnostic and prognostic marker for osteosarcoma

Journal of Surgical Research

Volumn 194, Issue 2, 2015, Pages 505-510

  Cai, Haikang ^a   Zhao, Hui ^b   Tang, Jie ^a   Wu, Haishan ^b  

^a Xuhui Central Hospital   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Diagnosis; MicroRNA 195; Osteosarcoma; Prognosis; Real time quantitative reverse transcription polymerase chain reaction; Serum

Indexed keywords

ALKALINE PHOSPHATASE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE; MICRORNA; MICRORNA 195; UNCLASSIFIED DRUG; MIRN195 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; BLOOD; CASE CONTROL STUDY; CHINA; EPIDEMIOLOGY; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS;

BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OSTEOSARCOMA; PROGNOSIS;

EID: 84924857245     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.11.025     Document Type: Article

References (27)

1. L. Mirabello, R.J. Troisi, and S.A. Savage Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program Cancer 115 2009 1531
2. G. Ottaviani, and N. Jaffe The epidemiology of osteosarcoma Cancer Treat Res 152 2009 3
3. S. Bruland, H. Bauer, T. Alvegaard, and S. Smeland Treatment of osteosarcoma. The Scandinavian sarcoma group experience Cancer Treat Res 152 2009 309
4. N. Federman, N. Bernthal, F.C. Eiber, and W.D. Tap The multidisciplinary management of osteosarcoma Curr Treat Options Oncol 10 2009 82
5. E.E. Pakos, A.D. Nearchou, and R.J. Grimer Prognostic factors and outcomes for osteosarcoma: an international collaboration Eur J Cancer 45 2009 2367
6. J.C. Clark, C.R. Dass, and P.F. Choong A review of clinical and molecular prognostic factors in osteosarcoma J Cancer Res Clin Oncol 134 2008 281
7. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281
8. L.P. Lim, N.C. Lau, and P. Garrett-Engele Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs Nature 433 2005 769
9. D.M. Dykxhoorn MicroRNAs and metastasis: little RNAs go a long way Cancer Res 70 2010 6401
10. T. Wurdinger, and F.F. Costa Molecular therapy in the microRNA era Pharmacogenomics J 7 2007 297
11. P.S. Meltzer Cancer genomics: small RNAs with big impacts Nature 435 2005 745
12. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat Rev Cancer 6 2006 857
13. J.F. He, Y.M. Luo, X.H. Wan, and D. Jiang Biogenesis of MiRNA-195 and its role in biogenesis, the cell cycle, and apoptosis J Biochem Mol Toxicol 25 2011 404
14. M. Lagos-Quintana, R. Rauhut, J. Meyer, A. Borkhardt, and T. Tuschl New microRNAs from mouse and human RNA 9 2003 175
15. Y. Yang, M. Li, and S. Chang MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells Mol Med Rep 10 2014 2643
16. F.L. Zhao, Y.C. Dou, and X.F. Wang Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer Mol Biol Rep 41 2014 5913
17. H. Guo, W. Li, T. Zheng, and Z. Liu miR-195 targets HDGF to inhibit proliferation and invasion of NSCLC cells Tumour Biol 35 2014 8861
18. L. Wang, L. Qian, X. Li, and J. Yan MicroRNA-195 inhibits colorectal cancer cell proliferation, colony-formation and invasion through targeting CARMA3 Mol Med Rep 10 2014 473
19. H. Deng, Y. Guo, and H. Song MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer Gene 518 2013 351
20. Y. Lin, J. Wu, and H. Chen Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells FEBS Lett 586 2012 442
21. J.H. Mao, R.P. Zhou, and A.F. Peng microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN Oncol Lett 4 2012 1125
22. A.G. Huvos Osteosarcoma in adolescents and young adults: new developments and controversies. Commentary on pathology Cancer Treat Res 62 1993 375
23. G. Rosen, B. Caparros, and A.G. Huvos Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy Cancer 49 1982 1221
24. S. Fleige, V. Walf, S. Huch, C. Prgomet, J. Sehm, and M.W. Pfaffl Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR Biotechnol Lett 28 2006 1601
25. C. Croce Introduction to the role of microRNAs in cancer diagnosis, prognosis, and treatment Cancer J 18 2012 213
26. P. Baldi, S. Brunak, Y. Chauvin, C.A. Andersen, and H. Nielsen Assessing the accuracy of prediction algorithms for classification: an overview Bioinformatics 16 2000 412
27. D.L. Zanette, F. Rivadavia, and G.A. Molfetta miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia Braz J Med Biol Res 40 2007 1435